Peak HumanDatabase
    All Research
    PAPER CTT-INMeta-Analysis2010

    Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-Analysis of Data from 170,000 Participants in 26 Randomised Trials

    Cholesterol Treatment Trialists' Collaboration meta-analysis of 26 statin RCTs showing each 1 mmol/L LDL reduction lowers major vascular events by about one-fifth.

    Evidence

    —

    Not Rated

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    The Lancet

    Nov 2010

    03

    Structured Methods

    Study Design
    Meta-Analysis
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (2010). Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-Analysis of Data from 170,000 Participants in 26 Randomised Trials. The Lancet. https://doi.org/10.1016/S0140-6736(10)61350-5

    DOI

    10.1016/S0140-6736(10)61350-5

    PubMed

    21067804

    Source

    Publisher

    Journal

    The Lancet

    05

    Indexing

    Biomarkers

    ldl-c
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation
    See your Peak Human Score How it works